Evanson Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253K Hold
2,968
0.01% 283
2025
Q4
$235K Hold
2,968
0.01% 305
2025
Q3
$237K Hold
2,968
0.01% 294
2025
Q2
$270K Hold
2,968
0.02% 278
2025
Q1
$278K Sell
2,968
-6,184
-68% -$554K 0.02% 250
2024
Q4
$832K Buy
9,152
+5
+0.1% +$477 0.06% 135
2024
Q3
$950K Buy
9,147
+4
+0% +$408 0.07% 124
2024
Q2
$887K Buy
9,143
+545
+6% +$50.3K 0.07% 126
2024
Q1
$774K Buy
8,598
+32
+0.4% +$2.71K 0.06% 134
2023
Q4
$683K Buy
8,566
+5
+0.1% +$376 0.06% 136
2023
Q3
$609K Buy
8,561
+6
+0.1% +$449 0.06% 139
2023
Q2
$659K Buy
8,555
+5
+0.1% +$387 0.06% 133
2023
Q1
$643K Buy
8,550
+105
+1% +$7.81K 0.06% 130
2022
Q4
$665K Sell
8,445
-253
-3% -$19K 0.07% 123
2022
Q3
$611K Buy
8,698
+5
+0.1% +$392 0.07% 129
2022
Q2
$697K Sell
8,693
-1,323
-13% -$103K 0.08% 118
2022
Q1
$760K Buy
10,016
+12
+0.1% +$951 0.07% 123
2021
Q4
$854K Buy
10,004
+12
+0.1% +$937 0.08% 114
2021
Q3
$812K Buy
9,992
+12
+0.1% +$953 0.08% 121
2021
Q2
$812K Buy
9,980
+11
+0.1% +$899 0.08% 118
2021
Q1
$786K Sell
9,969
-818
-8% -$64.1K 0.12% 112
2020
Q4
$922K Buy
10,787
+681
+7% +$56.3K 0.15% 94
2020
Q3
$780K Buy
10,106
+11
+0.1% +$839 0.14% 89
2020
Q2
$740K Buy
10,095
+13
+0.1% +$923 0.15% 90
2020
Q1
$669K Buy
10,082
+12
+0.1% +$846 0.16% 84
2019
Q4
$693K Buy
10,070
+13
+0.1% +$886 0.14% 93
2019
Q3
$739K Sell
10,057
-9
-0.1% -$653 0.15% 88
2019
Q2
$721K Buy
10,066
+12
+0.1% +$852 0.15% 90
2019
Q1
$689K Sell
10,054
-138
-1% -$8.91K 0.14% 93
2018
Q4
$607K Sell
10,192
-287
-3% -$18K 0.14% 95
2018
Q3
$702K Sell
10,479
-4,287
-29% -$286K 0.14% 90
2018
Q2
$957K Buy
14,766
+3,113
+27% +$204K 0.19% 74
2018
Q1
$835K Buy
11,653
+11
+0.1% +$792 0.17% 84
2017
Q4
$878K Sell
11,642
-23
-0.2% -$1.68K 0.18% 84
2017
Q3
$850K Buy
11,665
+461
+4% +$33.2K 0.18% 82
2017
Q2
$831K Sell
11,204
-665
-6% -$49.4K 0.19% 82
2017
Q1
$869K Buy
11,869
+32
+0.3% +$2.24K 0.21% 79
2016
Q4
$775K Buy
11,837
+11
+0.1% +$754 0.22% 83
2016
Q3
$877K Sell
11,826
-40
-0.3% -$2.96K 0.25% 69
2016
Q2
$869K Buy
11,866
+60
+0.5% +$4.27K 0.26% 68
2016
Q1
$834K Buy
11,806
+11
+0.1% +$732 0.29% 70
2015
Q4
$786K Sell
11,795
-77
-0.6% -$5.12K 0.29% 68
2015
Q3
$753K Sell
11,872
-309
-3% -$20.2K 0.28% 75
2015
Q2
$797K Buy
12,181
+330
+3% +$22.4K 0.28% 80
2015
Q1
$822K Buy
11,851
+9
+0.1% +$622 0.29% 76
2014
Q4
$819K Buy
11,842
+10
+0.1% +$675 0.3% 71
2014
Q3
$772K Buy
11,832
+10
+0.1% +$660 0.31% 69
2014
Q2
$806K Buy
11,822
+10
+0.1% +$670 0.31% 74
2014
Q1
$766K Buy
11,812
+10
+0.1% +$630 0.34% 71
2013
Q4
$770K Buy
+11,802
New +$755K 0.34% 68

Other funds holding CL

Evanson Asset Management's CL Position: Q1 2026 in Review

Evanson Asset Management held its Colgate-Palmolive (CL) position steady in Q1 2026 at 2,968 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #283.

Evanson Asset Management first reported a position in CL in Q4 2013 and has held it in 50 quarters since. The position peaked at $957K in Q2 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Evanson Asset Management held 2,968 shares of Colgate-Palmolive worth $253K as of Q1 2026.
  • Evanson Asset Management left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.01% of Evanson Asset Management's portfolio in Q1 2026, its #283 holding.
  • Evanson Asset Management first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 50 quarters since.
  • Evanson Asset Management's Colgate-Palmolive position peaked at $957K in Q2 2018.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Evanson Asset Management's 13F filing for Q1 2026, filed 8 Apr 2026.